Not only does this treatment failure burden the healthcare system with excess costs, it can also be devastating for patients who end up right back where they started
Table of Contents Why GLP-1 Medicines Cause Headaches Glucagon-like peptide-1 (GLP-1) receptor agonists including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda) are increasingly prescribed for type 2 diabetes management and weight loss
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in patients with type 2 diabetes on metformin and glimepiride (AWARD-2)
There is no established pharmacological mechanism by which GLP-1 receptor activation would directly cause muscle pain or damage
Key Technical Highlights 3
CMSs efforts to provide Medicare coverage of GLP-1s for obesity could offer substantial benefits to millions of Medicare beneficiaries, given the high demand for these medications